1. Epigenetics TGF-beta/Smad Autophagy Apoptosis Anti-infection
  2. PKC Autophagy Apoptosis HIV RABV
  3. Rottlerin

Rottlerin  (Synonyms: Mallotoxin; NSC 56346; NSC 94525)

Cat. No.: HY-18980 Purity: 98.45%
Handling Instructions Technical Support

Rottlerin, a natural product purified from Mallotus Philippinensis, is a specific PKC inhibitor, with IC50 values for PKCδ of 3-6 μM, PKCα,β,γ of 30-42 μM, PKCε,η,ζ of 80-100 μM. Rottlerin acts as a direct mitochondrial uncoupler, and stimulates autophagy by targeting a signaling cascade upstream of mTORC1. Rottlerin induces apoptosis via caspase 3 activation. Rottlerin inhibits HIV-1 integration and Rabies virus (RABV) infection.

For research use only. We do not sell to patients.

CAS No. : 82-08-6

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 22 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Rottlerin purchased from MedChemExpress. Usage Cited in: Virol Sin. 2025 Dec 27:S1995-820X(25)00177-4.  [Abstract]

    Fluorescence microscopy imaging of FHM cells infected with rVHSV-EGFP after treatment with varying concentrations of Rottlerin (2, 4, 6, 8, 10 μM) to assess GFP fluorescence intensity.

    Rottlerin purchased from MedChemExpress. Usage Cited in: EMBO Mol Med. 2024 Apr;16(4):1004-1026.  [Abstract]

    Vero E6 cells were infected for 1 or 2 days with TAHV at MOI 0.1 either non-treated (NT) or treated with 100 nM Bafilomycin A1 (Baf A1), 10 µM RG10b or 20 µM Rottlerin. Quantification of TAHV RNA, normalized by GAPDH RNA (control), was measured by RT-qPCR.

    Rottlerin purchased from MedChemExpress. Usage Cited in: EMBO Mol Med. 2024 Apr;16(4):1004-1026.  [Abstract]

    Cytotoxicity in non-infected (NI) and TAHV-infected OPAB with 10 µM RG10b or 20 µM Rottlerin treatment at 0, 2, 4, and 7 dpi.

    Rottlerin purchased from MedChemExpress. Usage Cited in: Virol Sin. 2022 Oct;37(5):685-694.  [Abstract]

    Treatment of Rottlerin (2.5 μM) throughout the infection showed a pronounced reduction of protein levels.

    Rottlerin purchased from MedChemExpress. Usage Cited in: Virol Sin. 2022 Oct;37(5):685-694.  [Abstract]

    All the DMSO-treated mice died while 75% of the Rottlerin (6 mg/kg, i.p.)-treated mice survived.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Rottlerin, a natural product purified from Mallotus Philippinensis, is a specific PKC inhibitor, with IC50 values for PKCδ of 3-6 μM, PKCα,β,γ of 30-42 μM, PKCε,η,ζ of 80-100 μM. Rottlerin acts as a direct mitochondrial uncoupler, and stimulates autophagy by targeting a signaling cascade upstream of mTORC1. Rottlerin induces apoptosis via caspase 3 activation[1][2][3]. Rottlerin inhibits HIV-1 integration and Rabies virus (RABV) infection[4][5].

    IC50 & Target[1][4]

    PKCδ

    3 μM (IC50, Porcine spleen)

    PKCα

    30 μM (IC50, baculovirus-infected Sf9 insect cells)

    PKCγ

    40 μM (IC50, baculovirus-infected Sf9 insect cells)

    PKCβ

    42 μM (IC50, baculovirus-infected Sf9 insect cells)

    PKCη

    82 μM (IC50, baculovirus-infected Sf9 insect cells)

    PKCζ

    100 μM (IC50, baculovirus-infected Sf9 insect cells)

    PKCε

    100 μM (IC50, baculovirus-infected Sf9 insect cells)

    CaM kinase III

    5.3 μM (IC50, EF-2 kinase activity in cytosol of murine pancreas)

    CKII

    30 μM (IC50, holoenzyme expressed in E.coli)

    PKA

    78 μM (IC50, catalytic subunit from porcine heart)

    HIV-1

     

    Cellular Effect
    Cell Line Type Value Description References
    COLO 205 IC50
    > 20 μM
    Compound: 1
    Cytotoxicity against human COLO205 cells after 48 hrs by MTT assay
    Cytotoxicity against human COLO205 cells after 48 hrs by MTT assay
    [PMID: 24041234]
    HL-60 IC50
    9 μM
    Compound: 1
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
    [PMID: 24041234]
    Hep 3B2 IC50
    0.25 μM
    Compound: 13
    Anticancer activity against human Hep3B cells assessed as inhibition of cell proliferation incubated for 4 days by MTS assay
    Anticancer activity against human Hep3B cells assessed as inhibition of cell proliferation incubated for 4 days by MTS assay
    [PMID: 33873056]
    HepG2 IC50
    > 20 μM
    Compound: 1
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    [PMID: 24041234]
    Huh-7 IC50
    0.57 μM
    Compound: 13
    Anticancer activity against human Huh-7 cells assessed as inhibition of cell proliferation incubated for 4 days by MTS assay
    Anticancer activity against human Huh-7 cells assessed as inhibition of cell proliferation incubated for 4 days by MTS assay
    [PMID: 33873056]
    MIA PaCa-2 IC50
    8 μM
    Compound: 1
    Cytotoxicity against human MIAPaCa2 cells after 48 hrs by MTT assay
    Cytotoxicity against human MIAPaCa2 cells after 48 hrs by MTT assay
    [PMID: 24041234]
    PC-3 IC50
    > 20 μM
    Compound: 1
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
    [PMID: 24041234]
    Sf9 IC50
    1.9 μM
    Compound: Rottlerin
    Inhibition of His-tagged human PRAK expressed in Sf9 cells
    Inhibition of His-tagged human PRAK expressed in Sf9 cells
    [PMID: 10998351]
    In Vitro

    Rottlerin (20 μM, 2/6/24 hours) dramatically decreases the cyclin D-1 mRNA levels in a time-dependent manner in primary HMVEC[2].
    Rottlerin (20 μM) exhibits cell proliferation in HMVEC[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Western Blot Analysis[2]

    Cell Line: Primary HMVEC (Human Microvascular Endothelial Cell).
    Concentration: 20 μM.
    Incubation Time: 2, 6, 24 hours.
    Result: Dramatically decreased the cyclin D-1 mRNA levels in a time-dependent manner. After 2 h of treatment, the mRNA level was reduced to 50% of the control, to circa 40% after 6 h, and to 20% after 24 h. Consistently, a similar trend was observed in the protein levels, where the decrease was circa 50% after 2 h, 80% after 6 h, and to almost undetectable levels after 24 h.

    Cell Proliferation Assay[2]

    Cell Line: Primary HMVEC (Human Microvascular Endothelial Cell).
    Concentration: 20 μM.
    Incubation Time: 24/48 hours.
    Result: Exhibited a strong growth inhibition, with a reduction in thymidine incorporation respect to the control cells (DMSO 0.1%) of circa 75% and 80%, respectively.
    In Vivo

    Rottlerin (20 mg/kg, gavage 5 days per week, once daily, for 6 weeks) inhibits AsPC-1 pancreatic tumor growth in Balb C nude mice with no toxicity[3].
    Rottlerin inhibits tumor cell proliferation, and induces apoptosis through activation of caspase-3 and cleavage of poly(ADP-ribose) polymerase (PARP)[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Balb C nude mice (4-6 weeks old) with AsPC-1 cells (2×106 cells mixed with Matrigel, 50:50 ratio) injection[3].
    Dosage: 0 or 20 mg/kg.
    Administration: Gavage 5 days per week, once daily, for 6 weeks.
    Result: Inhibited AsPC-1 pancreatic tumor growth in Balb C nude mice and had no effect on the body weight of AsPC-1 tumor-bearing mice.
    Molecular Weight

    516.54

    Formula

    C30H28O8

    CAS No.
    Appearance

    Solid

    Color

    Brown to reddish brown

    SMILES

    O=C(/C=C/C1=CC=CC=C1)C2=C3C(C=CC(C)(O3)C)=C(C(CC4=C(C(C)=C(C(C(C)=O)=C4O)O)O)=C2O)O

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : 12.5 mg/mL (24.20 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.9360 mL 9.6798 mL 19.3596 mL
    5 mM 0.3872 mL 1.9360 mL 3.8719 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 1.25 mg/mL (2.42 mM); Clear solution

      This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 1.25 mg/mL (2.42 mM); Clear solution

      This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL Corn oil, and mix evenly.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.5% CMC-Na/saline water

      Solubility: 22 mg/mL (42.59 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 98.45%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.9360 mL 9.6798 mL 19.3596 mL 48.3990 mL
    5 mM 0.3872 mL 1.9360 mL 3.8719 mL 9.6798 mL
    10 mM 0.1936 mL 0.9680 mL 1.9360 mL 4.8399 mL
    15 mM 0.1291 mL 0.6453 mL 1.2906 mL 3.2266 mL
    20 mM 0.0968 mL 0.4840 mL 0.9680 mL 2.4199 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Rottlerin
    Cat. No.:
    HY-18980
    Quantity:
    MCE Japan Authorized Agent: